Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Tim A. Ahles"'
Autor:
Janelsins MC; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Heckler CE; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Peppone LJ; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Kamen C; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Mustian KM; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Mohile SG; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Magnuson A; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Kleckner IR; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Guido JJ; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Young KL; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Conlin AK; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Weiselberg LR; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Mitchell JW; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Ambrosone CA; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Ahles TA; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Morrow GR; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Feb 10; Vol. 35 (5), pp. 506-514. Date of Electronic Publication: 2016 Dec 28.
Autor:
Harvey J. Cohen, Martine Extermann, Tim A. Ahles, Arti Hurria, Danielle Tometich, Brent J. Small, Jeanne S. Mandelblatt, Claudine Isaacs, Heather S. L. Jim, Asma Dilawari, James C. Root, Andrew J. Saykin, George Luta, Deena Graham, Sunita K. Patel, Jaeil Ahn, Xingtao Zhou, Brenna C. McDonald, Judith E. Carroll, Wanting Zhai, Paul B. Jacobsen, Neelima Denduluri
Publikováno v:
Cancer
BACKGROUND Little is known about longitudinal symptom burden, its consequences for well-being, and whether lifestyle moderates the burden in older survivors. METHODS The authors report on 36-month data from survivors aged ≥60 years with newly diagn
Autor:
Wanting Zhai, Deena Graham, James C. Root, Brent J. Small, Judith E. Carroll, Paul B. Jacobsen, Arti Hurria, Robert S. Stern, Martine Extermann, Danielle Tometich, Tim A. Ahles, Jeanne S. Mandelblatt, Asma Dilawari, Neelima Denduluri, George Luta, Kelly N.H. Nudelman, Brenna C. McDonald, Xingtao Zhou, Jonathan D. Clapp, Andrew J. Saykin, Heather S.L. Jim, Claudine Isaacs
Publikováno v:
Cancer
BACKGROUND Sleep disturbance and genetic profile are risks for cognitive decline in noncancer populations, yet their role in cancer-related cognitive problems remains understudied. This study examined whether sleep disturbance was associated with wor
Autor:
Brent J. Small, Jeanne S. Mandelblatt, Arti Hurria, Heather S.L. Jim, Brenna C. McDonald, James C. Root, Andrew J. Saykin, Deena Graham, Paul B. Jacobsen, Robert S. Stern, Tim A. Ahles, George Luta, Jonathan D. Clapp
Publikováno v:
Archives of Clinical Neuropsychology. 33:956-963
OBJECTIVE: To evaluate how use of different reference populations affects estimates of breast cancer-related cognitive impairment rates. METHODS: Patients aged ≥60 years with stage 0–3 breast cancer (n = 371) and matched non-cancer controls (n =
Autor:
Charles E. Heckler, Luke J. Peppone, Lora Weiselberg, Charles Kamen, Supriya G. Mohile, Tim A. Ahles, Jerry W. Mitchell, Joseph J. Guido, Gary R. Morrow, Karen M. Mustian, Alison Conlin, Christine A. Ambrosone, Kelley Lynn Young, Michelle C. Janelsins, Allison Magnuson, Ian R. Kleckner
Publikováno v:
Journal of Clinical Oncology. 35:506-514
Purpose Cancer-related cognitive impairment is an important problem for patients with breast cancer, yet its trajectory is not fully understood. Some previous cancer-related cognitive impairment research is limited by heterogeneous populations, small
Autor:
Felipe Cardenal, Tim A. Ahles, Pablo Ripollés, James C. Root, Antoni Rodríguez-Fornells, Marta Simó, Jordi Bruna, Josep Jové, Arturo Navarro, Lucía Vaquero
Publikováno v:
Journal of Thoracic Oncology. 10(1):38-45
Introduction No study has examined structural brain changes specifically associated with chemotherapy in a lung cancer population. The aim of this cross-sectional study was to assess differences in brain structure between small-cell lung cancer patie
Publikováno v:
Journal of Clinical Oncology. 32:2617-2626
The number of patients with cancer who are age 65 years or older (hereinafter “older”) is increasing dramatically. One obvious aspect of cancer care for this group is that they are experiencing age-related changes in multiple organ systems, inclu
Autor:
Scott Turner, Meghan McGuckin, Darlene V. Howard, Jeanne S. Mandelblatt, John W. VanMeter, Paul B. Jacobsen, Neelima Denduluri, Brenna C. McDonald, Arti Hurria, Andrew J. Saykin, Robert S. Stern, Tim A. Ahles, Tiffani Traina
Publikováno v:
Seminars in Oncology. 40:709-725
There is a fairly consistent, albeit non-universal body of research documenting cognitive declines after cancer and its treatments. While few of these studies have included subjects aged 65 years and older, it is logical to expect that older patients
Publikováno v:
Brain Imaging and Behavior. 7:491-500
Chemotherapy-induced amenorrhea (CIA) often occurs in pre- and peri-menopausal BC patients, and while cancer/chemotherapy and abrupt estrogen loss have separately been shown to affect cognition and brain function, studies of the cognitive effects of
Objective Patient-reported cognition generally exhibits poor concordance with objectively assessed cognitive performance. In this article, we introduce latent regression Rasch modeling and provide a step-by-step tutorial for applying Rasch methods as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3aa6c06ab4ca0a97bbae659d326aaf5
https://europepmc.org/articles/PMC4876936/
https://europepmc.org/articles/PMC4876936/